A rare disease advocacy group on Wednesday urged the government to remove the age cap on funding treatment for a spinal cord disease that causes serious muscle weakness among patients and may leave them paralysed.
Rare Disease Hong Kong said currently, only those aged 25 or below will get government funding to buy medicine for spinal muscular atrophy (SMA) treatment for life…
阅读更多（Read More）